Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis.
Hoffmann MC, Fadle N, Regitz E, Kos IA, Cetin O, Lesan V, Preuss KD, Zaks M, Stöger E, Zimmer V, Klemm P, Assmann G, Pfeifer J, Bittenbring JT, Bewarder M, Vogt T, Pföhler C, Thurner B, Kessel C, Thurner L. Hoffmann MC, et al. Among authors: bittenbring jt. Immunol Lett. 2024 Sep 10;270:106926. doi: 10.1016/j.imlet.2024.106926. Online ahead of print. Immunol Lett. 2024. PMID: 39265919 Free article.
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma.
Christofyllakis K, Kaddu-Mulindwa D, Lesan V, Rixecker T, Kos IA, Held G, Regitz E, Pfreundschuh M, Bittenbring JT, Thurner L, Poeschel V, Ziepert M, Altmann B, Bewarder M. Christofyllakis K, et al. Among authors: bittenbring jt. Ann Hematol. 2024 Nov;103(11):4599-4606. doi: 10.1007/s00277-024-05973-9. Epub 2024 Sep 4. Ann Hematol. 2024. PMID: 39227453 Free PMC article.
Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma-A retrospective multicenter cohort study.
Dilbaz ZG, Denker S, Ankermann C, Bittenbring JT, Kaddu-Mulindwa D, Kunte AS, Hünecke S, Poeschel V, Stilgenbauer S, Thurner L, Na IK, Bewarder M, Christofyllakis K. Dilbaz ZG, et al. Among authors: bittenbring jt. Eur J Haematol. 2024 Nov;113(5):675-684. doi: 10.1111/ejh.14268. Epub 2024 Jul 31. Eur J Haematol. 2024. PMID: 39086181
Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy.
Acker F, Chromik J, Tiedjen E, Wolf S, Vischedyk JB, Makowka P, Enßle JC, Kouidri K, Sebastian M, Steffen B, Oellerich T, Serve H, Neubauer A, Schäfer JA, Bittenbring JT. Acker F, et al. Among authors: bittenbring jt. Eur J Haematol. 2024 Nov;113(5):623-630. doi: 10.1111/ejh.14278. Epub 2024 Jul 18. Eur J Haematol. 2024. PMID: 39023132
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated anti-tumor efficacy of tafasitamab.
Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, Altmeyer S, Bittenbring JT, Augsberger C, Ilieva-Babinsky K, Haskamp S, Beier F, Lischer C, Vera J, Lührmann A, Bertz S, Völkl S, Jacobs B, Steidl S, Mackensen A, Bruns H. Biedermann A, et al. Among authors: bittenbring jt. Haematologica. 2024 Jun 27. doi: 10.3324/haematol.2023.284795. Online ahead of print. Haematologica. 2024. PMID: 38934068 Free article.
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.
Hoffmann MC, Cavalli G, Fadle N, Cantoni E, Regitz E, Fleser O, Klemm P, Zaks M, Stöger E, Campochiaro C, Tomelleri A, Baldissera E, Bittenbring JT, Zimmer V, Pfeifer J, Fischer Y, Preuss KD, Bewarder M, Thurner B, Fuehner S, Foell D, Dagna L, Kessel C, Thurner L. Hoffmann MC, et al. Among authors: bittenbring jt. J Clin Immunol. 2024 Jan 17;44(2):45. doi: 10.1007/s10875-023-01642-0. J Clin Immunol. 2024. PMID: 38231276 Free PMC article.
52 results